unknown
Stage
About
FREZENT Biological Solutions develops first-in-class antibody therapies targeting dormant cancer cells to prevent cancer recurrence, initially focusing on head and neck cancer and expanding to other cancers like osteosarcoma and pancreatic cancer.
Explore FREZENT Biological Solutions's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.